{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:54:49Z","timestamp":1762206889081,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100020898","name":"Women's College Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009227","name":"Department of Medicine, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jid.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T04:45:06Z","timestamp":1680324306000},"page":"1340-1341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris"],"prefix":"10.1016","volume":"143","author":[{"given":"David O.","family":"Croitoru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.02.002_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","article-title":"Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial","volume":"62","author":"Bingham","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2023.02.002_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93222","article-title":"Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab","volume":"2","author":"Cho","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2023.02.002_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159721","article-title":"Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases","volume":"7","author":"Dayam","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2023.02.002_bib4","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jid.2022.12.023","article-title":"SARS-CoV-2 vaccination effectiveness in rituximab-treated patients affected by pemphigus vulgaris","volume":"143","author":"Fenizia","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.02.002_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.jid.2023.02.002_bib6","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2023.02.002_bib7","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1016\/S2665-9913(22)00098-4","article-title":"Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform","volume":"4","author":"MacKenna","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jid.2023.02.002_bib8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jaad.2021.02.073","article-title":"Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy","volume":"84","author":"Montagnon","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.02.002_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3389\/fimmu.2019.01375","article-title":"Identification of autoreactive B cell subpopulations in peripheral blood of autoimmune patients with pemphigus vulgaris","volume":"10","author":"Pollmann","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2023.02.002_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-4632.2004.02533.x","article-title":"Pemphigus in the Mediterranean region of Turkey: a study of 148 cases","volume":"45","author":"Uzun","year":"2006","journal-title":"Int J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23000842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23000842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:52:05Z","timestamp":1762206725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23000842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022202X23000842"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.02.002","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.12.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}